Enterome to present promising clinical progress on its OncoMimics pipeline and Mimicry Platform at Jefferies Healthcare Conference

PARIS, May 23, 2022 /PRNewswire/ -- Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its bacterial Mimicry drug discovery platform

Related Keywords

New York ,United States ,Paris ,France General ,France ,Kostenloser Wertpapierhandel ,Prnewswire Enterome ,Pierre Belichard ,Sylvie Berrebi Mark ,Head Of External Communications ,Jefferies Healthcare Conference ,New York City ,Thursday June ,External Communications ,Mark Swallow ,Enterome ,Present ,Romising ,Linical ,Progress ,Ncomimics ,Pipeline ,Mimicry ,Platform ,Efferies ,Healthcare ,Conference ,